Document is current
Any future updates will be listed below
-
Authors
Goldmacher, Victor S.
Gershteyn, Iosif
Chari, Ravi
Kovtun, Yelena
-
Funding
Funding for this research was provided by:
ImmuVia, Inc.
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 10 March 2025
First Online: 22 March 2025
Declarations
:
: All authors are affiliated with ImmuVia Inc. IMV-M is currently under development at ImmuVia Inc. as a potential oncology drug candidate.
